Showing results (491-500 of 571) with videos related to
Sort By:
Pageof 58
Parkinsonism & Related Disorders|May 21, 2019
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionNaveed Malek, Sofia Kanavou, Michael A Lawton, et al.Oncogene|July 29, 1998
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like familyJ M Varley, P Chapman, G McGown, et al.Investigative Ophthalmology & Visual Science|July 2, 2010
Complement factor h autoantibodies and age-related macular degenerationBaljean Dhillon, Alan F Wright, Adnan Tufail, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2011
Depression and anxiety related subtypes in Parkinson's diseaseRichard G Brown, Sabine Landau, John V Hindle, et al.Journal of the American Society of Nephrology : JASN|December 16, 2016
Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal DiseaseRachel C Challis, Troels Ring, Yaobo Xu, et al.Neuropathology and Applied Neurobiology|May 29, 2020
Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stressM Kurzawa-Akanbi, M Keogh, E Tsefou, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2016
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's diseaseNaveed Malek, Michael A Lawton, Diane M A Swallow, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 13, 2017
Mild cognitive impairment as a risk factor for Parkinson's disease dementiaJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 31, 2020
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's DiseaseJoanna Wilson, Alison J Yarnall, Chesney E Craig, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Estimates of benefits and harms of prophylactic use of aspirin in the general populationJ Cuzick, M A Thorat, C Bosetti, et al.Pageof 58